Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Parkinson's disease (PD) is a neurodegenerative disorder characterized by degeneration of dopaminergic neurons in the substantia nigra. We previously mapped a locus for a rare familial form of PD to chromosome 1p36 (PARK6). Here we show that mutations in PINK1 (PTEN-induced kinase 1) are associated with PARK6. We have identified two homozygous mutations affecting the PINK1 kinase domain in three consanguineous PARK6 families: a truncating nonsense mutation and a missense mutation at a highly conserved amino acid. Cell culture studies suggest that PINK1 is mitochondrially located and may exert a protective effect on the cell that is abrogated by the mutations, resulting in increased susceptibility to cellular stress. These data provide a direct molecular link between mitochondria and the pathogenesis of PD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Evidence for mitochondrial dysfunction is provided by mutations in genes that are associated with mitochondria in familial PD [e.g., mitochondrial kinase PINK (PTEN-induced kinase 1) and Parkin (Valente et al., 2004;Poole et al., 2008)], and features of PD are caused by mitochondrial toxins (Bove ´et al., 2005).”
From Depletion of 26S Proteasomes in Mouse Brain Neurons Causes Neurodegeneration and Lewy-Like Inclusions Resembling Human Pale Bodies (2008) · cites this paper as Valente et al., 2004
In the citing paper
“Mutations in PARKIN and PINK1 are the leading causes of autosomal recessive PD [9, 10].”
From miR-27a and miR-27b regulate autophagic clearance of damaged mitochondria by targeting PTEN-induced putative kinase 1 (PINK1) (2016) · cites this paper as [10]
In the citing paper
“Multiple neurodegenerative diseases have dysfunctional mitophagic processes in neurons, as described in Parkinson’s disease (PD) (16), Huntington’s disease (17), amyotrophic lateral sclerosis (ALS) (18), and Alzheimer’s disease (AD) (19,20).”
From Alzheimer's Disease–Associated Amyloid-β Precursor Protein Prevents Aging Stress–Induced Mitophagy and Fumarate Depletion to Improve Antitumor Immunity (2025) · cites this paper as [16]
In the citing paper
“A causal association has been established between autosomal recessive forms of PD and mutations affecting the mitophagy regulators PINK1 (PTEN‐induced putative kinase 1) and PRKN/PARK2 (Parkin RBR E3 ubiquitin protein ligase) (Kitada et al, 1998; Valente et al, 2004; Narendra et al, 2008; Matsuda et al, 2010).”
From Autophagy in major human diseases (2021) · cites this paper as Valente et al, 2004
In the citing paper
“The most studied mechanism for mitophagy in mammalian cells is mediated by the cytoplasmic E3 ubiquitin ligase PARKIN [210] and the mitochondrial membrane kinase PINK1 [211].”
From AMPK, Mitochondrial Function, and Cardiovascular Disease (2020) · cites this paper as [211]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
Betarbet, R., Sherer, T. B., MacKenzie, G., Garcia-Osuna, M., Panov, A. V., & Greenamyre, J. T. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,683
α-Synuclein is phosphorylated in synucleinopathy lesions
Fujiwara, H., Hasegawa, M., Dohmae, N., Kawashima, A., Masliah, E., Goldberg, M. S., Shen, J., Takio, K., & Iwatsubo, T. (2002) · Nature Cell Biology · doi:10.1038/ncb748 · Cited by 2,132
Buée, L., Bussière, T., Buée-Scherrer, V., Delacourte, A., & Hof, P. R. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00019-9 · Cited by 2,015
Molecular Pathways of Neurodegeneration in Parkinson's Disease
Dawson, T. M., & Dawson, V. L. (2003) · Science · doi:10.1126/science.1087753 · Cited by 1,663
Nicklas, W. J., Vyas, I., & Heikkila, R. E. (1985) · Life Sciences · doi:10.1016/0024-3205(85)90146-8 · Cited by 1,262
Understanding cell death in parkinson's disease
Jenner, P., & Olanow, C. W. (1998) · Annals of Neurology · doi:10.1002/ana.410440712 · Cited by 685
Sherer, T. B., Betarbet, R., Stout, A. K., Lund, S., Baptista, M., Panov, A. V., Cookson, M. R., & Greenamyre, J. T. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-16-07006.2002 · Cited by 581
Valente, E. M., Bentivoglio, A. R., Dixon, P. H., Ferraris, A., Ialongo, T., Frontali, M., Albanese, A., & Wood, N. W. (2001) · The American Journal of Human Genetics · doi:10.1086/319522 · Cited by 493
Self-citationChen, H.-K., Fernandez-Funez, P., Acevedo, S. F., Lam, Y. C., Kaytor, M. D., Fernandez, M. H., Aitken, A., Skoulakis, E. M. C., Orr, H. T., Botas, J., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00349-0 · Cited by 414
Research works printed but not linked: 1
- A. H. Schapiraet al., Lancet2, 1269 (1989).
Cited by
Items 601–700 of 1,043
Casas, S., Gomis, R., Gribble, F. M., Altirriba, J., Knuutila, S., & Novials, A. (2007) · Diabetes · doi:10.2337/db07-0178 · Cited by 148
Two-stage association study and meta-analysis of mitochondrial DNA variants in Parkinson disease
Hudson, G., Nalls, M., Evans, J. R., Breen, D. P., Winder-Rhodes, S., Morrison, K. E., Morris, H. R., Williams-Gray, C. H., Barker, R. A., Singleton, A. B., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e318294b434 · Cited by 147
Self-citationα-Synuclein and Mitochondrial Dysfunction in Parkinson’s Disease
Mullin, S., & Schapira, A. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8394-x · Cited by 146
Duda, J., Pötschke, C., & Liss, B. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13572 · Cited by 170
The role of neuroimaging in Parkinson’s disease
Bidesi, N., Andersen, I. V., Windhorst, A. D., Shalgunov, V., & Herth, M. M. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15516 · Cited by 172
Sim, C. H., Lio, D. S. S., Mok, S. S., Masters, C. L., Hill, A. F., Culvenor, J. G., & Cheng, H.-C. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl398 · Cited by 147
Disruption of Protein Quality Control in Parkinson's Disease
Cook, C., Stetler, C., & Petrucelli, L. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009423 · Cited by 147
Mitochondrial Contribution to Parkinson's Disease Pathogenesis
Schapira, A. H. V., & Gegg, M. (2011) · Parkinson's Disease · doi:10.4061/2011/159160 · Cited by 146
Miro phosphorylation sites regulate Parkin recruitment and mitochondrial motility
Shlevkov, E., Kramer, T., Schapansky, J., LaVoie, M. J., & Schwarz, T. L. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1612283113 · Cited by 145
Tan, S. H., Karri, V., Tay, N. W. R., Chang, K. H., Ah, H. Y., Ng, P. Q., Ho, H. S., Keh, H. W., & Candasamy, M. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.12.101 · Cited by 146
Neuronal autophagy and mitophagy in Parkinson's disease
Lizama, B. N., & Chu, C. T. (2021) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2021.100972 · Cited by 159
Sun, M., Latourelle, J. C., Wooten, G. F., Lew, M. F., Klein, C., Shill, H. A., Golbe, L. I., Mark, M. H., Racette, B. A., Perlmutter, J. S., et al. (2006) · Archives of Neurology · doi:10.1001/archneur.63.6.826 · Cited by 146
Tools and techniques to measure mitophagy using fluorescence microscopy
Dolman, N. J., Chambers, K. M., Mandavilli, B., Batchelor, R. H., & Janes, M. S. (2013) · Autophagy · doi:10.4161/auto.24001 · Cited by 144
Regulation of mitochondrial dynamics in astrocytes: Mechanisms, consequences, and unknowns
Jackson, J. G., & Robinson, M. B. (2018) · Glia · doi:10.1002/glia.23252 · Cited by 145
A cut short to death: Parl and Opa1 in the regulation of mitochondrial morphology and apoptosis
Pellegrini, L., & Scorrano, L. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402145 · Cited by 158
Positioning mitochondrial plasticity within cellular signaling cascades
Soubannier, V., & McBride, H. M. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.07.008 · Cited by 165
What causes cell death in Parkinson's disease?
Gupta, A., Dawson, V. L., & Dawson, T. M. (2009) · Annals of Neurology · doi:10.1002/ana.21573 · Cited by 143
Jurcău, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111847 · Cited by 163
Conn, K. J., Gao, W., McKee, A. C., Lan, M. S., Ullman, M. D., Eisenhauer, P. B., Fine, R. E., & Wells, J. M. (2004) · Brain Research · doi:10.1016/j.brainres.2004.07.026 · Cited by 144
Storz, P. (2006) · Science's STKE · doi:10.1126/stke.3322006re3 · Cited by 143
History of the Selective Autophagy Research: How Did It Begin and Where Does It Stand Today?
Kirkin, V. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.05.010 · Cited by 142
ROCK inhibitors upregulate the neuroprotective Parkin-mediated mitophagy pathway
Moskal, N., Riccio, V., Bashkurov, M., Taddese, R., Datti, A., Lewis, P. N., & Angus McQuibban, G. (2020) · Nature Communications · doi:10.1038/s41467-019-13781-3 · Cited by 142
Hristova, V. A., Beasley, S. A., Rylett, R. J., & Shaw, G. S. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808700200 · Cited by 142
Malkus, K. A., Tsika, E., & Ischiropoulos, H. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-24 · Cited by 142
Loreto, A., Hill, C. S., Hewitt, V. L., Orsomando, G., Angeletti, C., Gilley, J., Lucci, C., Sanchez-Martinez, A., Whitworth, A. J., Conforti, L., et al. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104678 · Cited by 131
“Pink1 is involved in mitochondrial quality control and mutations in this protein are linked to early-onset recessive PD (Pickrell and Youle, 2015; Valente et al., 2001, 2004).”
BackgroundAutophagy impairment in Parkinson’s disease
Karabiyik, C., Lee, M. J., & Rubinsztein, D. C. (2017) · Essays in Biochemistry · doi:10.1042/ebc20170023 · Cited by 140
Uddin, M. S., Mamun, A. A., Labu, Z. K., Hidalgo‐Lanussa, O., Barreto, G. E., & Ashraf, G. M. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27588 · Cited by 141
Emerging views of OPTN (optineurin) function in the autophagic process associated with disease
Qiu, Y., Wang, J., Li, H., Yang, B., Wang, J., He, Q., & Weng, Q. (2022) · Autophagy · doi:10.1080/15548627.2021.1908722 · Cited by 134
Mitophagy in neurological disorders
Zhang, L., Dai, L., & Li, D. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02334-5 · Cited by 152
PINK1 Is a Negative Regulator of Growth and the Warburg Effect in Glioblastoma
Agnihotri, S., Golbourn, B., Huang, X., Remke, M., Younger, S., Cairns, R. A., Chalil, A., Smith, C. A., Krumholtz, S.-L., Mackenzie, D., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3079 · Cited by 139
The PINK1–Parkin axis: An Overview
Tanaka, K. (2020) · Neuroscience Research · doi:10.1016/j.neures.2020.01.006 · Cited by 146
Mitochondrial dynamics in Parkinson's disease
Van Laar, V. S., & Berman, S. B. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.03.019 · Cited by 140
Bit-by-bit autophagic removal of parkin-labelled mitochondria
Yang, J., & Yang, W. Y. (2013) · Nature Communications · doi:10.1038/ncomms3428 · Cited by 151
Holmans, P., Moskvina, V., Jones, L., Sharma, M., The International Parkinson's Disease Genomics Consortium (IPDGC), Vedernikov, A., Buchel, F., Sadd, M., Bras, J. M., Bettella, F., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/dds492 · Cited by 139
Self-citationKazlauskaite, A., Kelly, V., Johnson, C., Baillie, C., Hastie, C. J., Peggie, M., Macartney, T., Woodroof, H. I., Alessi, D. R., Pedrioli, P. G. A., et al. (2014) · Open Biology · doi:10.1098/rsob.130213 · Cited by 139
Self-citationKhasnavis, S., & Pahan, K. (2012) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-011-9286-3 · Cited by 138
Primary Skin Fibroblasts as a Model of Parkinson's Disease
Auburger, G., Klinkenberg, M., Drost, J., Marcus, K., Morales-Gordo, B., Kunz, W. S., Brandt, U., Broccoli, V., Reichmann, H., Gispert, S., et al. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8245-1 · Cited by 137
Self-citationCreation of an Open-Access, Mutation-Defined Fibroblast Resource for Neurological Disease Research
Wray, S., Self, M., NINDS Parkinson's Disease iPSC Consortium, NINDS Huntington's Disease iPSC Consortium, NINDS ALS iPSC Consortium, Lewis, P. A., Taanman, J.-W., Ryan, N. S., Mahoney, C. J., Liang, Y., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043099 · Cited by 138
Self-citationSchiesling, C., Kieper, N., Seidel, K., & Krüger, R. (2008) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2008.00952.x · Cited by 138
Scheele, C., Petrovic, N., Faghihi, M. A., Lassmann, T., Fredriksson, K., Rooyackers, O., Wahlestedt, C., Good, L., & Timmons, J. A. (2007) · BMC Genomics · doi:10.1186/1471-2164-8-74 · Cited by 138
Clinicogenetic study of PINK1 mutations in autosomal recessive early-onset parkinsonism
Li, Y., Tomiyama, H., Sato, K., Hatano, Y., Yoshino, H., Atsumi, M., Kitaguchi, M., Sasaki, S., Kawaguchi, S., Miyajima, H., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000164009.36740.4e · Cited by 138
Loss of PINK1 Increases the Heart's Vulnerability to Ischemia-Reperfusion Injury
Siddall, H. K., Yellon, D. M., Ong, S.-B., Mukherjee, U. A., Burke, N., Hall, A. R., Angelova, P. R., Ludtmann, M. H. R., Deas, E., Davidson, S. M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062400 · Cited by 135
Burbulla, L. F., Schelling, C., Kato, H., Rapaport, D., Woitalla, D., Schiesling, C., Schulte, C., Sharma, M., Illig, T., Bauer, P., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq370 · Cited by 136
Eye Movements in Parkinson’s Disease and Inherited Parkinsonian Syndromes
Pretegiani, E., & Optican, L. M. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00592 · Cited by 160
Karimi-Moghadam, A., Charsouei, S., Bell, B., & Jabalameli, M. R. (2018) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-018-0587-4 · Cited by 136
Animal Models for Parkinson’s Disease Research: Trends in the 2000s
Kin, K., Yasuhara, T., Kameda, M., & Date, I. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215402 · Cited by 137
Kanwar, J. R., Sun, X., Punj, V., Sriramoju, B., Mohan, R. R., Zhou, S., Chauhan, A., & Kanwar, R. K. (2011) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2011.08.006 · Cited by 152
Ubiquitin pathways in neurodegenerative disease
Atkin, G., & Paulson, H. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00063 · Cited by 136
Mitochondrial turnover in the heart
Gottlieb, R. A., & Gustafsson, Å. B. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.11.017 · Cited by 136
Role of the endolysosomal system in Parkinson’s disease
Vidyadhara, D. J., Lee, J. E., & Chandra, S. S. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14820 · Cited by 136
Polygenic risk of Parkinson disease is correlated with disease age at onset
Escott‐Price, V., for the International Parkinson's Disease Genomics Consortium, Nalls, M. A., Morris, H. R., Lubbe, S., Brice, A., Gasser, T., Heutink, P., Wood, N. W., Hardy, J., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24335 · Cited by 135
Self-citationMitochondrial DNA and primary mitochondrial dysfunction in Parkinson's disease
Giannoccaro, M. P., La Morgia, C., Rizzo, G., & Carelli, V. (2017) · Movement Disorders · doi:10.1002/mds.26966 · Cited by 135
Beetles as Model Organisms in Physiological, Biomedical and Environmental Studies – A Review
Adamski, Z., Bufo, S. A., Chowański, S., Falabella, P., Lubawy, J., Marciniak, P., Pacholska‐Bogalska, J., Salvia, R., Scrano, L., Słocińska, M., et al. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00319 · Cited by 153
Autophagy lysosomal pathway dysfunction in Parkinson's disease; evidence from human genetics
Senkevich, K., & Gan-Or, Z. (2020) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2019.11.015 · Cited by 132
Liu, W., Vives-Bauza, C., Acín-Peréz-, R., Yamamoto, A., Tan, Y., Li, Y., Magrané, J., Stavarache, M. A., Shaffer, S., Chang, S., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004597 · Cited by 135
Genetics of Parkinson disease.
Domingo, A., & Klein, C. (2018) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-63233-3.00014-2 · Cited by 23
Targeting Mitochondrial Impairment in Parkinson's Disease: Challenges and Opportunities
Prasuhn, J., Davis, R. L., & Kumar, K. R. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.615461 · Cited by 141
Villavicencio-Tejo, F., & Quintanilla, R. A. (2021) · Antioxidants · doi:10.3390/antiox10071069 · Cited by 153
Egawa, N., Yamamoto, K., Inoue, H., Hikawa, R., Nishi, K., Mori, K., & Takahashi, R. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.156430 · Cited by 134
Structure and Function of Parkin, PINK1, and DJ-1, the Three Musketeers of Neuroprotection
Trempe, J.-F., & Fon, E. A. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00038 · Cited by 133
Oh, C.-K., Sultan, A., Platzer, J., Dolatabadi, N., Soldner, F., McClatchy, D. B., Diedrich, J. K., Yates, J. R., Ambasudhan, R., Nakamura, T., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.10.068 · Cited by 133
Impact of Dopamine Oxidation on Dopaminergic Neurodegeneration
Zhang, S., Wang, R., & Wang, G. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00454 · Cited by 141
Hedrich, K., Hagenah, J., Djarmati, A., Hiller, A., Lohnau, T., Lasek, K., Grünewald, A., Hilker, R., Steinlechner, S., Boston, H., et al. (2006) · Archives of Neurology · doi:10.1001/archneur.63.6.833 · Cited by 133
Paul, S. (2008) · BioEssays · doi:10.1002/bies.20852 · Cited by 157
Hung, S., Liou, H., Kang, K., Wu, R., Wen, C.-C., & Fu, W. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.048611 · Cited by 133
Mitochondrial quality control by the Pink1/Parkin system
Rüb, C., Wilkening, A., & Voos, W. (2017) · Cell and Tissue Research · doi:10.1007/s00441-016-2485-8 · Cited by 132
Mitochondrial alterations in Parkinson’s disease: new clues
Vila, M., Ramonet, D., & Perier, C. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05604.x · Cited by 131
Bras, J., Singleton, A., Cookson, M. R., & Hardy, J. (2008) · The FEBS Journal · doi:10.1111/j.1742-4658.2008.06709.x · Cited by 132
Unconventional initiation of PINK1/Parkin mitophagy by Optineurin
Nguyen, T. N., Sawa-Makarska, J., Khuu, G., Lam, W. K., Adriaenssens, E., Fracchiolla, D., Shoebridge, S., Bernklau, D., Padman, B. S., Skulsuppaisarn, M., et al. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.04.021 · Cited by 130
Delivery of drugs and macromolecules to the mitochondria for cancer therapy
Lu, P., Bruno, B. J., Rabenau, M., & Lim, C. S. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.10.023 · Cited by 135
Choline dehydrogenase interacts with SQSTM1/p62 to recruit LC3 and stimulate mitophagy
Park, S., Choi, S.-G., Yoo, S.-M., Son, J. H., & Jung, Y.-K. (2014) · Autophagy · doi:10.4161/auto.32177 · Cited by 131
Van Laar, V. S., & Berman, S. B. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.05.015 · Cited by 131
Mitochondrial autophagy in neural function, neurodegenerative disease, neuron cell death, and aging
Batlevi, Y., & La Spada, A. R. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.09.009 · Cited by 130
PINK1-Parkin Pathway Activity Is Regulated by Degradation of PINK1 in the Mitochondrial Matrix
Thomas, R. E., Andrews, L. A., Burman, J. L., Lin, W.-Y., & Pallanck, L. J. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004279 · Cited by 130
Neuropathology of α‐synuclein propagation and braak hypothesis
McCann, H., Cartwright, H., & Halliday, G. M. (2016) · Movement Disorders · doi:10.1002/mds.26421 · Cited by 130
Niclosamide, a Drug with Many (Re)purposes
Kadri, H., Lambourne, O. A., & Mehellou, Y. (2018) · ChemMedChem · doi:10.1002/cmdc.201800100 · Cited by 135
Briston, T., & Hicks, A. R. (2018) · Biochemical Society Transactions · doi:10.1042/bst20180025 · Cited by 131
Wang, W.-W., Han, R., He, H.-J., Li, J., Chen, S.-Y., Gu, Y., & Xie, C. (2021) · Aging · doi:10.18632/aging.202868 · Cited by 128
Parkinson’s disease: A genetic perspective
Belin, A. C., & Westerlund, M. (2008) · The FEBS Journal · doi:10.1111/j.1742-4658.2008.06301.x · Cited by 131
PINK1, Parkin, and DJ-1 mutations in Italian patients with early-onset parkinsonism
Klein, C., Djarmati, A., Hedrich, K., Schäfer, N., Scaglione, C. L. M., Marchese, R., Kock, N., Schüle, B., Hiller, A., Lohnau, T., et al. (2005) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201455 · Cited by 158
Mitophagy in Acute Kidney Injury and Kidney Repair
Wang, Y., Cai, J., Tang, C., & Dong, Z. (2020) · Cells · doi:10.3390/cells9020338 · Cited by 130
“PARK2 is a cytosolic ubiquitin E3 ligase [68].”
BackgroundOne-step generation of triple gene-targeted pigs using CRISPR/Cas9 system
Wang, X., Cao, C., Huang, J., Yao, J. T., Hai, T., Zheng, Q., Wang, X., Zhang, H., Qin, G., Cheng, J., et al. (2016) · Scientific Reports · doi:10.1038/srep20620 · Cited by 151
Casein kinase 1α: biological mechanisms and theranostic potential
Jiang, S., Zhang, M., Sun, J., & Yang, X. (2018) · Cell Communication and Signaling · doi:10.1186/s12964-018-0236-z · Cited by 130
“been detected in both familial and sporadic PD [107, 130].”
BackgroundRehman, M. U., Sehar, N., Dar, N. J., Khan, A., Arafah, A., Rashid, S., Rashid, S. M., & Ganaie, M. A. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104961 · Cited by 130
Pilsl, A., & Winklhofer, K. F. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0902-3 · Cited by 139
Okatsu, K., Kimura, M., Oka, T., Tanaka, K., & Matsuda, N. (2015) · Journal of Cell Science · doi:10.1242/jcs.161000 · Cited by 128
The role of monogenic genes in idiopathic Parkinson’s disease
Reed, X., Bandrés-Ciga, S., Blauwendraat, C., & Cookson, M. R. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.11.012 · Cited by 129
Miller, S., & Muqit, M. M. K. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.04.029 · Cited by 129
Self-citationPOLG mutations and Alpers syndrome
Davidzon, G., Mancuso, M., Ferraris, S., Quinzii, C. M., Hirano, M., Peters, H. L., Kirby, D. M., Thorburn, D. R., & DiMauro, S. (2005) · Annals of Neurology · doi:10.1002/ana.20498 · Cited by 130
Targeting mitophagy in Parkinson's disease
Clark, E. H., de la Torre, A. V., Hoshikawa, T., & Briston, T. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.rev120.014294 · Cited by 137
Benedetto, A., Au, C., & Aschner, M. (2009) · Chemical Reviews · doi:10.1021/cr800536y · Cited by 128
Cooper, J. F., Machiela, E., Dues, D. J., Spielbauer, K. K., Senchuk, M. M., & Van Raamsdonk, J. M. (2017) · Scientific Reports · doi:10.1038/s41598-017-16637-2 · Cited by 126
Intra- and Intercellular Quality Control Mechanisms of Mitochondria
Kiriyama, Y., & Nochi, H. (2017) · Cells · doi:10.3390/cells7010001 · Cited by 127
Mitochondrial dynamics, a key executioner in neurodegenerative diseases
Panchal, K., & Tiwari, A. K. (2018) · Mitochondrion · doi:10.1016/j.mito.2018.11.002 · Cited by 136
Neuropathology of incidental Lewy body & prodromal Parkinson’s disease
Koeglsperger, T., Rumpf, S.-L., Schließer, P., Struebing, F. L., Brendel, M., Levin, J., Trenkwalder, C., Höglinger, G. U., & Herms, J. W. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00622-7 · Cited by 159
Homozygous PINK1 C‐terminus mutation causing early‐onset parkinsonism
Rohé, C. F., Montagna, P., Breedveld, G., Cortelli, P., Oostra, B. A., & Bonifati, V. (2004) · Annals of Neurology · doi:10.1002/ana.20247 · Cited by 126
Self-citationThe Etiopathogenesis of Parkinson Disease and Suggestions for Future Research. Part I
Litvan, I., Halliday, G., Hallett, M., Goetz, C. G., Rocca, W., Duyckaerts, C., Ben-Shlomo, Y., Dickson, D. W., Lang, A. E., Chesselet, M.-F., et al. (2007) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3180415e42 · Cited by 125
Mechanisms of Neuronal Homeostasis: Autophagy in the Axon
Maday, S. (2016) · Brain Research · doi:10.1016/j.brainres.2016.03.047 · Cited by 110
From autophagy to mitophagy: the roles of P62 in neurodegenerative diseases
Liu, H., Dai, C., Fan, Y., Guo, B., Ren, K., Sun, T., & Wang, W. (2017) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-017-9727-7 · Cited by 131
Impact of gene mutation in the development of Parkinson's disease
Selvaraj, S., & Piramanayagam, S. (2019) · Genes & Diseases · doi:10.1016/j.gendis.2019.01.004 · Cited by 140
Metadata
- Authors
- Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., Albanese, A., Nussbaum, R., González-Maldonado, R., Deller, T., Salvi, S., Cortelli, P., Gilks, W. P., Latchman, D. S., Harvey, R. J., Dallapiccola, B., Auburger, G., & Wood, N. W.
- Affiliations
- National Hospital for Neurology and Neurosurgery (GB)
- CSS IRCCS, Mendel Institute, viale Regina Margherita 261, 00198 Rome, Italy.
- Goethe University Frankfurt (DE)
- Università Cattolica del Sacro Cuore (IT)
- National Institutes of Health (US)
- University of Modena and Reggio Emilia (IT)
- Corresponding author
- Valente, Enza Maria
- ORCID
- Venue
- Science
- Published
- 2004-05-21
- Volume
- 304
- Issue
- 5674
- Pages
- 1158-1160
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2136388422
- Cited by
- 3,481
- References
- 19
- Citations by year
- 2026: 101 · 2025: 140 · 2024: 168 · 2023: 133 · 2022: 158 · 2021: 187 · 2020: 182 · 2019: 158 · 2018: 167 · 2017: 189 · 2016: 147 · 2015: 151 · 2014: 158 · 2013: 177 · 2012: 163
- FWCI
- 109.31
- Type
- journal article
- Language
- en
- Open access
- green
- figshare.com
- Licence
- cc-by
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Funders
- Parkinson's UK (G-4029)
- Brain Research Trust
- Deutsche Forschungsgemeinschaft
- Ministero della Salute
- Medical Research Council
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Keywords
- Parkinson's disease, PINK1, mitochondrial dysfunction, dopaminergic neuron loss, consanguineous family, nonsense mutation, missense mutations, mitochondrial localization
- MeSH terms
- PTEN-Induced Putative Kinase, Amino Acid Sequence, Animals, Exons, Humans, Leupeptins, Membrane Potentials, Mitochondria, Molecular Sequence Data, Mutation, Neurons, Parkinson Disease, Protein Kinases, Transfection, Apoptosis, Protein Structure, Tertiary, Oxidative Stress, Codon, Nonsense, COS Cells, Mutation, Missense, Cell Line, Tumor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.